secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001437749-26-001196
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene raises $28M in registered direct offering from Boxer, Coastlands, Vivo Capital
--------------------------------------------------------------------------------

- Offering totals $28M in three tranches; initial $6.03M closed Jan 13, 2026 at $6.50/unit.
- Additional tranches: $6.7M Series A warrants contingent on PDUFA date, $15.6M Series B on FDA approval.
- Warrants exercise price adjustable based on stock price milestones; redeemable if in-the-money.
- Investors include Boxer Capital, Coastlands Capital, Vivo Capital; BTIG as sole placement agent.
- Proceeds expected to fund operations into early 2027, supporting NDA and potential CNM-Au8 commercialization in ALS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/0001437749-26-001196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/clnn20260106_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer